COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
Trial ID or NCT#
Status
Purpose
The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.
Official Title
Multicenter Prospective Analysis of Treatment Outcome in Patients With Large Acoustic Neuromas
Eligibility Criteria
- - Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the cerebellopontine angle are eligible for this trial. - Patients that are deemed good surgical candidates based on age, general health, genetic predispositions, and hearing in contralateral side would be included as the subjects of this trial. - Although we would include patients with neurofibromatosis II in this trial, considering their genetic predisposition for recurrence, we would analyze their outcome as a separate group.
- - Patients who have received any form of treatment of their acoustic neuromas prior to enrollment in the study including surgery or radiation therapy.
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Ashkan Monfared, MD
(202) 741-3250
View on ClinicalTrials.gov
About this Clinical Trial
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
Your Message Will Go To
ashkan monfared, MD202-741-3250